

Blend + GHK-Cu Set
BPC-157 + TB-500 Blend 20mg + GHK-Cu 50mg. A combined repair and dermal-matrix research set.


GLOW Blend 70mg + GHK-Cu 50mg. Copper-peptide focused preparation set for dermal research models.
Select size
Quantity
Total
$108.00
That's the price. No inflated list, no permanent “discount” code to make it look cheaper than it is.
Certificate for this lot is pending. Every batch we ship is published at /coa before it goes out.
For Research Use Only. Not for Human Consumption.
Products supplied by Synthrex Biotech LLC are intended strictly for in-vitro laboratory research and development by qualified professionals. They are not drugs, foods, cosmetics, or dietary supplements, and are not approved by the FDA for human or veterinary use. They are not sold for, and must not be used for, human or animal consumption or administration of any kind. Synthrex Biotech LLC is not a compounding pharmacy or chemical compounding facility as defined under section 503A of the Federal Food, Drug, and Cosmetic Act, and is not an outsourcing facility as defined under section 503B of that Act. By purchasing, you affirm that you are a qualified researcher acquiring these materials for lawful research purposes only. A Safety Data Sheet (SDS/MSDS) is available on request for every compound.
Sold by Synthrex Biotech LLC. A Safety Data Sheet (SDS) is available on request at support@synthrexbiotech.com.
Every vial carries its own batch number and its own published certificate, exactly as it would if bought separately. No published literature characterises this combination as a single entity.
A combined BPC-157, GHK-Cu and TB-500 preparation studied in dermal and repair research contexts.
A co-formulation of three separately characterised compounds — BPC-157, the copper tripeptide GHK-Cu (identified in human plasma by Loren Pickart in 1973), and TB-500. The blend is a supplier formulation, not a molecule described in the literature, and has no discovery history of its own.
Full research notes and sources for GLOW Blend →A copper-binding tripeptide complex investigated in dermal-matrix and wound-research models.
GHK is a naturally occurring tripeptide — glycyl-L-histidyl-L-lysine — identified in human plasma by Loren Pickart in 1973. Pickart was studying why plasma from young donors behaved differently from plasma from older donors in liver-cell cultures, and isolated GHK as the active factor. The copper complex GHK-Cu followed once it became clear that the tripeptide binds Cu(II) with high affinity at physiological pH, and that the copper is integral to its behaviour rather than incidental. It is one of the few compounds in this catalog with a genuinely long and independently replicated literature.
Full research notes and sources for GHK-Cu →Batch releases & restocks
We publish an independent certificate for every lot before it ships. Join the Lab List and we'll tell you when a new one lands and when a sold-out compound is back — plus 15% off your first order, shown on screen the second you join.
Batch and restock notices from Synthrex Biotech LLC. No dosing advice, ever. One-click unsubscribe on every email.


BPC-157 + TB-500 Blend 20mg + GHK-Cu 50mg. A combined repair and dermal-matrix research set.


KLOW Blend 80mg + KPV 10mg. A four-compound blend paired with an alpha-MSH fragment for multi-pathway research.


CJC-1295 + Ipamorelin Blend 10mg + Ipamorelin 10mg. GHRH analog and ghrelin-receptor agonist research set.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.